DermaDetect's intelligent software seamlessly integrates with existing systems, providing accessibility 24/7 and adopting an attractive pay-per-usage pricing model. The company recently secured a Seed Round investment on 21 August 2022, with the investment coming from Ariel Yaar. This investment is expected to propel DermaDetect's growth and expansion, positioning the company as a key player in the intersection of healthcare and advanced technology.
General Information
BounceWatch is an independent company data service, not affiliated with DermaDetect. To contact DermaDetect, visit dermadetect.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
About DermaDetect
Taxonomy: AI-driven diagnostics, Skin disorders, Dermatology, Tele-medicine, Tele-dermatology, Artificial intelligence, Remote diagnosis, Patient care, Healthcare efficiency, Tele-health, Medical software, Healthcare innovation
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | Undisclosed | 1 |
Ariel Yaar
|
21 Aug 2022 |
| Seed Round | $2.20M | 3 | 01 Jan 2022 | |
| Seed Round | $1.86M | 2 |
Maccabi Fund, Israel Innovation Authority
|
01 Jan 2020 |
| Pre Seed Round | $1.20M | 3 | 01 Aug 2017 |
DermaDetect Alternatives & Competitors
View All AlternativesHautarztbehandlung inkl. Therapieempfehlung und Rezept durch Hautfachärzt:innen – 24/7 verfügbar.
Prévention et détection des pathologies de la peau.
Certified Dermatology AI Skin Scanner & Mole Checker apps & API. Early detection, better skincare. ...
FAQ About DermaDetect
Source: BounceWatch company record for DermaDetect, https://bouncewatch.com/company/dermadetect, updated 30 December 2024. When citing, please name BounceWatch and link this page.